Clinical Trials Directory

Trials / Unknown

UnknownNCT05105997

Dexamethasone/ Erector Spinae Plane Block Analgesia in Laparoscopic Cholecystectomy

Dexamethasone as a Bupivacaine Adjuvant in Ultrasound-guided Erector Spinae Plane Block for Patients Undergoing Laparoscopic Cholecystectomy: a Randomized Double-blind Study

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Although considered a minimally invasive procedure, laparoscopic cholecystectomy (LC) frequently results in moderate to severe immediate postoperative pain.

Detailed description

Although considered a minimally invasive procedure, laparoscopic cholecystectomy (LC) frequently results in moderate to severe immediate postoperative pain. In addition to predominant visceral pain, nearly half of all patients suffer from shoulder pain in the early postoperative period. The most likely reason is sub-diaphragmatic irritation, which is transmitted by the phrenic nerve, causing referred pain in the C4 dermatome. Due to multiple sources of pain, multimodal analgesia approaches have been used in the perioperative period following LC.

Conditions

Interventions

TypeNameDescription
DRUGDexamethasone/ Erector Spinae Plane BlockPatients will receive bilateral Ultrasound-guided Erector Spinae Plane Block with bupivacaine and dexamethasone 15 minutes before skin incision
DRUGErector Spinae Plane BlockPatients will receive bilateral Ultrasound-guided Erector Spinae Plane Block with bupivacaine and one ml of normal saline 15 minutes before skin incision.

Timeline

Start date
2022-12-01
Primary completion
2023-07-01
Completion
2023-07-01
First posted
2021-11-03
Last updated
2022-09-23

Source: ClinicalTrials.gov record NCT05105997. Inclusion in this directory is not an endorsement.